ESC 365 - Could diastolic perfomance parameters be earlier markers for cardiotoxicity in high risk cancer patients?

ESC Premium Access

Could diastolic perfomance parameters be earlier markers for cardiotoxicity in high risk cancer patients?

Session: Cardiovascular Disease in Special Populations ePosters

Topic: Cardio-Oncology

Speaker: Doctor A. Farcas (Cluj Napoca, RO)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Doctor Anca Daniela Farcas

University of Medicine and Pharmacy of Cluj Napoca, Cluj Napoca (Romania)

0 follower

155 more presentations in this session

Implementation study of CT calcium score in patients with atypical angina pectoris and non-specific thoracic complaints in primary care: rationale, objectives, and design of the CONCRETE study

Speaker: Miss M. Koopman (Groningen, NL)

Serum uric acid possibly associated with abnormal left ventricular diastolic function in healthy individuals

Speaker: Doctor C. Liu (Taipei, TW)

Characteristics and health status of patients with and without confirmed HFpEF

Speaker: Professor C. Deaton (Cambridge, GB)

Evaluating the diagnostic and prognostic value of cardiac biomarkers for heart disease and major adverse cardiac events in patients with muscular dystrophy

Speaker: Mr A. Nikhanj (Edmonton, CA)

Heart involvement in type 1 and type 2 myotonic dystrophy. Insights from a 10-year follow-up study.

Speaker: Doctor F. Fioravanti (Milan, IT)

Access the full session

Cardiovascular Disease in Special Populations ePosters

Speakers: Doctor A. Farcas, Miss M. Koopman, Doctor C. Liu, Professor C. Deaton, Mr A. Nikhanj...

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources